Top 45 Biotech Angel Investors in Switzerland (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Penny Schiffer
Angel
|
4 | Switzerland, Germany, United Kingdom | Seed, Series A | Medical, Software, Health Care | $544k–$9.3M |
|
Andrew Keys
Angel
|
3 | United States, India, Norway | Seed, Pre-Seed, Series A | Software, Finance, Blockchain | $1M–$34M |
|
Daniel Gutenberg
Angel
|
2 | Switzerland, United States, Israel | Seed, Series A | Software, Artificial Intelligence, SaaS | $1.3M–$20M |
|
Chris Gibson
Angel
|
1 | United States, France, Switzerland | Series A, Seed | Biotechnology, Health Care, Life Science | $4.9M–$55M |
|
Igor Fish
Angel
|
1 | Switzerland | Series A | Medical, Health Care, Life Science | |
|
Ian Metcalfe
Angel
|
1 | Switzerland | Pre-Seed | Biotechnology | |
|
Marcello Campanelli
Angel
|
1 | Switzerland | Pre-Seed | Biotechnology | |
|
Delia Schrafl
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Patrick Delarive
Angel
|
1 | Switzerland | Seed | Security, Wireless, Wearables | |
|
Nicolas Mermod
Angel
|
1 | Switzerland | Series A | Medical, Health Care, Life Science | |
|
Mathias Maurer
Angel
|
1 | Switzerland | Seed, Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Ulf Claesson
Angel
|
1 | Switzerland | Seed | Biotechnology, Food and Beverage | |
|
Thorsten Schroeder
Angel
|
1 | United States, Brazil, Mexico | Seed, Series B | Children, E-Commerce, Electronics | $4M–$23M |
|
Peter Herger
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Balaji Srinivasan
Angel
|
1 | United States, India, Singapore | Seed, Pre-Seed, Series A | Blockchain, Cryptocurrency, Software | $450k–$28M |
|
Konstantin Othmer
Angel
|
1 | United States, Latvia, Germany | Seed, Pre-Seed | Automotive, Health Care, SaaS | $520k–$18M |
|
Young Sohn
Angel
|
1 | United States, Germany, Switzerland | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $200k–$110M |
|
Kirill Eves
Angel
|
1 | India, Switzerland, United Arab Emirates | Seed, Pre-Seed | B2B, Gaming, Medical | $3M–$18M |
|
Urs Berger
Angel
|
1 | Switzerland | Pre-Seed | Wellness, Neuroscience, Information Technology | |
|
Ted Kummert
Angel
|
1 | Switzerland, United States | Seed, Series A | CRM, Big Data, Software | |
|
Reinhard Ambros
Angel
|
1 | United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | |
|
Qiao Wang
Angel
|
1 | United States, Singapore, China | Seed, Pre-Seed, Venture - Series Unknown | Blockchain, Software, Cryptocurrency | $350k–$12M |
|
Helmut Deschauer
Angel
|
1 | Switzerland | Pre-Seed | Genetics, Oncology, Generative AI | $1.5M–$1.9M |
|
Lucian Wagner
Angel
|
1 | Switzerland | Seed, Venture - Series Unknown | Biotechnology, Music, Drones | $1.9M–$2M |
|
John Zimmer
Angel
|
1 | United States, Denmark, Switzerland | Seed, Series B | Mining, FinTech, Mineral | $5M–$193M |
|
Zürcher Kantonalbankand
Angel
|
1 | Switzerland | Seed, Series A, Series B | Medical Device, Energy, Leasing | $1.2M–$4.4M |
|
Nitin Sharma
Angel
|
1 | India, United States, Germany | Pre-Seed, Seed, Grant | Financial Services, Software, Information Technology | $165k–$11M |
|
Edward Ludwig
Angel
|
1 | Switzerland, United States | Seed, Series A, Corporate Round | Medical, Health Care, Biotechnology | |
|
Ronjon Nag
Angel
|
1 | United Kingdom, United States, Canada | Seed, Pre-Seed, Series B | Artificial Intelligence, Software, Health Care | $472k–$13M |
|
Katelyn Donnelly
Angel
|
1 | United States, Germany | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, Education | $600k–$13M |
|
Mark Nelson
Angel
|
1 | Switzerland, United States | Seed, Pre-Seed, Series A | Artificial Intelligence, B2B, CRM | |
|
Christopher Gibson
Angel
|
1 | United States, United Kingdom, France | Series A, Seed, Series B | Biotechnology, Health Care, Pharmaceutical | $5.4M–$55M |
|
Marc Maurer
Angel
|
1 | Switzerland | Series A | Artificial Intelligence, Software, Machine Learning | $16M–$18M |
|
Thomas Glocer
Angel
|
1 | United States, United Kingdom, Israel | Seed, Series A, Series C | Software, FinTech, Analytics | $1M–$27M |
|
Lukas Speiser
Angel
|
1 | Switzerland, Germany | Seed, Pre-Seed | Health Care, SaaS, Retail | $161k–$3M |
|
Tobias Reichmuth
Angel
|
1 | Switzerland | Seed, Angel, Pre-Seed | E-Commerce, Travel, Internet | $138k–$2.6M |
|
Thomas Zehnder
Angel
|
1 | Switzerland | Seed | Health Care, Life Science, Biotechnology | |
|
Arda Kara
Angel
|
1 | United States, Germany, Switzerland | Series A, Seed, Series B | Health Care, Medical, Software | $26M–$38M |
|
Miklos Stanek
Angel
|
1 | Switzerland | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Pharmaceutical | $5.8M–$7.7M |
|
Nicolas Weber
Angel
|
1 | Switzerland, United Kingdom | Seed, Pre-Seed | Genetics, Oncology, Health Care | |
|
Alexsis de Raadt-St. James
Angel
|
1 | United States, Switzerland, United Kingdom | Seed, Series A, Series B | Software, SaaS, Health Care | $250k–$24M |
|
Tej Tadi
Angel
|
1 | Switzerland | Seed | Robotics, Neuroscience | |
|
Emily Leproust
Angel
|
1 | United States, Switzerland | Seed | Biotechnology, Health Care, Product Research | $1.5M–$5.7M |
|
Philip Wels
Angel
|
1 | Switzerland | Pre-Seed, Seed | Information Technology, Sports, Software | |
|
Feike Sijbesma
Angel
|
1 | Switzerland, United Kingdom | Seed, Series B | Biotechnology, Bioinformatics, Pharmaceutical | |
| Access all 75 angel investors in Switzerland Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $544k–$9.3M; Series A $1.2M–$7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
Andrew Keys is the Co-Founder and Managing Partner of Andrew Keys. He previously worked for ConsenSys as a Head of Global Business Development. Andrew Keys attended Loyola University Maryland.
Show more...Investment focus
- Industry: Software, Finance, Blockchain
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Norway
Investor stats
- Total investments: 14
- Round size: Seed $1M–$34M; Pre-Seed $1.4M–$2.5M; Series A $14M–$15M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Stackr Labs — Micro-rollups to scale web3 applications
- Zivoe Finance — Join Zivoe in disrupting predatory high-interest lending.
- Ithaca Finance — Ithaca Finance a cross-chain derivatives trading and settlements protocol, is composed of an on-chain settlement layer with an innovative off-chain matching engine.
Daniel joined VI Partners in July 2003 as a Venture Partner focusing on IT. He started his career as Chairman and CEO of Gutenberg Communication Systems AG, a company he founded in 1991. Subsequent to selling Gutenberg Communication Systems AG to the Telindus Group in 2000, he became Country Manager of Telindus for Switzerland, Austria andHungary during the next two years, and he was also a member of the Executive Board. Since 2002 he has been taking consulting and advisory board assignments for various companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: Switzerland, United States, Israel
Investor stats
- Total investments: 31
- Round size: Seed $1.3M–$9.4M; Series A $3M–$20M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- fonio.ai — Founded in Vienna in 2024, fonio.ai provides AI-powered phone assistants that automate customer communication 24/7. The platform answers calls, forwards inquiries, books appointments, and integrates with CRM and ERP systems, while every interaction is transcribed and can be stored, shared, or connected to existing tools.
- aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
- NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Seed
- Geography: United States, France, Switzerland
Investor stats
- Total investments: 10
- Round size: Seed $4.9M–$14M; Series A $6.3M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Leash Biosciences — We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of protein to generate billions of data points, ideal for training advanced machine learning models.
Igor Fish
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Series A
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
Ian Metcalfe is an individual investor.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellX Biosolutions — CellX Biosolutions harnesses bacteria to sustainably treat chemical waste including PFAS, pharmaceuticals, and microplastics, offering innovative, eco-friendly waste management solutions.
Marcello Campanelli is a general manager at Parker Lord.
Show more...Investment focus
- Industry: Biotechnology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CellX Biosolutions — CellX Biosolutions harnesses bacteria to sustainably treat chemical waste including PFAS, pharmaceuticals, and microplastics, offering innovative, eco-friendly waste management solutions.
Delia Schrafl serves as an Advisor to the Investment Committee of Evoleen Invest AG.
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Patrick is a businessman active in real estate, wealth management, show business, hospitality, education and private equity, benefiting from a strong network. At Biowatch since November 2015.
Show more...Investment focus
- Industry: Security, Wireless, Wearables
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Biowatch — Biowatch is a user-friendly wrist veins biometric reader that functions as a security solution for mobile payment protection and smart device interaction. Users can access the app for enrolling their vein pattern and selecting applications and devices that needs to be connected to their Biowatch, wear their BioWatch and activate it by matchingtheir vein pattern with their enrolled reference, get PKI encrypted user code transmitted from their Biowatch, and start opening doors without the use of keys and passwords.Biowatch was launched by Joe Rice and Matthias Vanoni and is headquartered in Lausanne, Switzerland.
Nicolas Mermod
Show more...Investment focus
- Industry: Medical, Health Care, Life Science
- Stage:Series A
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- NewBiologix — NewBiologix operates as a technology innovation company, develops a proprietary and breakthroughDNA integration platform for the advanced engineering of human and mammaliancell lines.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Mathias Maurer
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Ulf Claesson
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MIRAI FOODS — Love meat? Mirai aims to produce the meat of the future by cultivating animal cells in a controlled environment
Thorsten Schroeder
Show more...Investment focus
- Industry: Children, E-Commerce, Electronics
- Stage:Seed, Series B
- Geography: United States, Brazil, Mexico
Investor stats
- Total investments: 11
- Round size: Seed $4M–$15M; Series B $18M–$23M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Storypod — The screen-free, educational audio toy that engages children independently & makes learning fun. Storypod delights toddlers, preschoolers, 1st, & 2nd graders with music, stories, songs, audiobooks, & podcasts. The Storypod audio player features recording from any phone, bedtime nightlight, sound machine, & white noise.
- TROCAFONE — Trocafone is the first end-to-end e-commerce marketplace of LATAM that enable people to buy and sell used electronics hassle free, focused on smartphones in Brazil. At Trocafone they improve the selling and buying experience by acquiring the devices from sellers, refurbishing and re-selling them as pre-owned certified. Buyers enjoy the greatdeals of a peer-to-peer marketplace combined with the service, convenience, and safety of a retail store. Sellers enjoy a streamlined experience since It takes seconds to sell an item, and shipping is effortless with Trocafone's pre-addressed, pre-stamped mailers.
- 4D Lifetec — 4D Lifetec is a biotechnology company promoting and developing screening and test systems for molecular diagnostics. It also offers a unique solution for DNA defect and repair based screening programs and is, therefore, the diagnostic method of the first choice. The company profits from different networks in science and healthcare.4D Lifetecprovides kits, reagents, download center, 4D life tanks, and service packages. They also offer cost savings for healthcare provider by its outstanding precision and a high degree of standardization both leading to a reduction of false positive results.4D Lifetec was founded by Dr. Arne Faisst and Nick Mijnssen in 2014 and is headquartered in Cham, Zug.
Peter Herger is a private investor.
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Balaji S. Srinivasan is the Co-Founder and Board Member of Coin Center. He was the CTO of Coinbase and cofounder of Counsyl, Earn, Teleport, and Coin Center. Dr. Srinivasan holds a BS, MS, and PhD in Electrical Engineering and an MS in Chemical Engineering from Stanford University. He also teaches the occasional class at Stanford, including anonline MOOC.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, India, Singapore
Investor stats
- Total investments: 271
- Round size: Seed $2.3M–$15M; Pre-Seed $450k–$4.2M; Series A $6M–$28M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Vorflux — Cloud agents that ship production code. An opinionated harness that runs the full SDLC on dedicated machines.
- BizScout — BizScout is an online platform of Off market deals for verified buyers and sellers.
- Warp — Warp is a payroll and compliance tool that makes it easy for founders to hire, onboard, and pay their employees.
Konstantin Othmer is the Co Founder & CEO at Speechpad.
Show more...Investment focus
- Industry: Automotive, Health Care, SaaS
- Stage:Seed, Pre-Seed
- Geography: United States, Latvia, Germany
Investor stats
- Total investments: 16
- Round size: Seed $520k–$18M; Pre-Seed $1M–$2.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- aiomics — Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers.
- elasticStage — Create your own vinyl or CD today. Upload music & artwork, order copies, or sell to fans for free with elasticStage. No costs, shipped in weeks not months.
- YOUTH — Full health check-up in less than 2 minutes!
Young Sohn is a Silicon Valley entrepreneur whose passion is building businesses and fostering emerging technologies that have the potential to transform the world for the better. Currently, Sohn serves as Corporate President and Chief Strategy Officer of Samsung Electronics and Chairman of the Board of HARMAN. He leads Samsung’s strategy forglobal innovation, investment, and new business creation, and led the company’s $8 billion acquisition of HARMAN. Prior to joining Samsung Electronics, Sohn served as CEO of two successful, public Silicon Valley companies and on the boards of Arm, Cadence, Cymer (ASML), and others. Under his leadership as CEO and board member, he took PLX Technologies, Synnex Technologies, and Inphi public. He was also a seed investor in some of the industry’s most innovative companies, including Bitfury, Fungible, Graphcore, and Zoom.Sohn is a leader of the global Tech for Good movement. He helped launch the Extreme Tech Challenge (XTC), the world’s largest startup competition for entrepreneurs addressing global challenges. He also serves as a North America board member at MIT Sloan, a senior advisor to the private equity firm Silver Lake Partners, a board member at Cadence, and an advisor for the University of California Innovation Council. Sohn holds a BS in electrical engineering from the University of Pennsylvania and an MS from the MIT Sloan School of Management. An avid outdoorsman, Sohn spends his personal time kite surfing, cycling, running, hiking, and competing in triathlons.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 25
- Round size: Seed $200k–$18M; Series A $20M–$80M; Series B $24M–$110M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Revolear — Revolutionize your dealmaking with Revolear, the end-to-end platform for structuring, proposing, negotiating, and approving deals. Designed for Humans. Powered by AI.
- Unique AI — Unlock the power of generative AI in Finance with Unique FinanceGPT. Get custom use cases and accurate insights in a secure, enterprise-ready platform.
- Perfect — A personalized talent-finding and engaging experience made for every team.
Kirill Eves is a visionary serial entrepreneur and founder with a proven track record of building successful profound fintech companies for the past 15 years.
Show more...Investment focus
- Industry: B2B, Gaming, Medical
- Stage:Seed, Pre-Seed
- Geography: India, Switzerland, United Arab Emirates
Investor stats
- Total investments: 3
- Round size: Seed $3M–$18M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
- Paytring — Enable merchants, PSPs, and banks to run multi-currency, multi-region payments through a single unified rail. 50+ PSP integrations, 100+ payment methods, global coverage.
- Playgama — Playgama is a fast-growing distributor of HTML5 games, connecting developers to an audience of 220 million monthly active players. We simplify game distribution and monetization, allowing developers to focus on creating exceptional games while we handle the rest. With open-source SDK, games distributed thought Playgama can reach players acrossleading high-traffic platforms, ensuring global exposure—from Europe to Asia and USA.
Urs Berger is the current President of Swiss Entrepreneurs Foundation. He previously worked at JAROWA AG as a Chairman of the Board. Urs Berger attended Northwestern University - Kellogg School of Management.
Show more...Investment focus
- Industry: Wellness, Neuroscience, Information Technology
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Ted joined Madrona in 2013 and brings his years of technical and operational leadership in enterprise technology to Madrona and the portfolio companies. As Venture Partner, Ted identifies new investments and provides strategic counsel and operational advice to Madrona portfolio companies. Prior to Madrona, Ted drove major product and businessinitiatives for Microsoft for more than two decades. At Microsoft, Kummert led teams across a broad set of technologies, including operating systems, consumer online services, enterprise security and enterprise application platform. As Corporate Vice President of the Data Platform Group, Kummert led the development of several key Microsoft enterprise products including SQL Server, SQL Server Parallel Data Warehouse, Windows Azure Data Services and Microsoft's business intelligence and big data offerings. Widely known as the "data chief" of Microsoft, he led the data platform business through a period of significant growth and drove the cloud and big data strategy for the platform. Ted began his career at Apple and HP.
Show more...Investment focus
- Industry: CRM, Big Data, Software
- Stage:Seed, Series A
- Geography: Switzerland, United States
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
- Tektonic AI — Tektonic unlocks new, previously impossible automation use cases from sales and revenue processes to broader business operations.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Reinhard Ambros
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Switzerland
Investor stats
- Total investments: 11
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- FORMA Therapeutics — FORMA Therapeutics is a biopharmaceutical company integrating transformative biology and chemistry to unlock targets and pathways that have been validated through genomic medicine as root causes or major drivers of human cancers.FORMA’s approach to accessing such high value drug targets, many of which pose significant challenges toconventional discovery approaches, is rooted in the concerted integration of its innovative drug discovery technologies and oncology expertise, enabling screening, discovery and rational development of a generation of small molecule drug candidates with cellular mechanisms of action. FORMA is building a pipeline of therapeutics directed at Achilles heels in human cancers, such as key targets associated with cancer stem cells, tumor cell metabolism, programmed cell death or epigenetic disease mechanisms.FORMA builds on the vision of its academic founders: Stuart Schreiber, Todd Golub and Michael Foley, each of the Broad Institute of Harvard and MIT. FORMA leverages its innovative drug discovery platform to address challenging targets and develop a robust internal pipeline of breakthrough oncology drugs.
- Aileron Therapeutics — Aileron Therapeutics - ALRN-6924 - myelopreservation
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Qiao Wang is a believer in decentralized technologies such as cryptocurrencies that shift the balance of power from the elite to the commoner.
Show more...Investment focus
- Industry: Blockchain, Software, Cryptocurrency
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United States, Singapore, China
Investor stats
- Total investments: 32
- Round size: Seed $1.1M–$12M; Pre-Seed $350k–$3M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- AltLayer — AltLayer is a system of highly scalable application-dedicated execution layers that derive security from an underlying L1/L2.
- NEBRA Labs — NEBRA Labs is a blockchain services company.
- Slide — Slide enables dApps to serve effortless web3 experiences to everyday users.
Helmut Deschauer is an angel investor.
Show more...Investment focus
- Industry: Genetics, Oncology, Generative AI
- Stage:Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 2
- Round size: Pre-Seed $1.5M–$1.9M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- ABSORA — ABSORA is pioneering breakthrough materials that outperform existing solutions in silencing noise and vibration.
- Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Lucian Wagner is the Chairman and Co-Founder of Launch in the US Alliance. Lucian has a truly global outlook with an extensive set of contacts in North America, Europe, and Asia. Lucian is a venture capitalist and entrepreneur with several successful start-ups to his credit. He has 20 years of semiconductor industry experience. Lucian was born inGermany, educated in the French school system, and went on to earn a B.Sc. in International Economics from the School of Foreign Service at Georgetown University (with a minor in Russian) and an MBA from INSEAD.
Show more...Investment focus
- Industry: Biotechnology, Music, Drones
- Stage:Seed, Venture - Series Unknown
- Geography: Switzerland
Investor stats
- Total investments: 6
- Round size: Seed $1.9M–$2M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- ENANTIOS — ENANTIOS specializes in creating benchtop analytical instruments that provide industries, research institutions, and academic facilities.
- Snowcookie — Ski tracking sensors by bode miller for racers and coaches
- Carewell — Carewell is influencing the way people work in healthcare by providing flexible digital solutions tailored to their specific needs.
John Zimmer is based out of San Francisco Bay Area, California and was the Vice Chair of the Board of Directors of Lyft. John Zimmer attended the Cornell University.
Show more...Investment focus
- Industry: Mining, FinTech, Mineral
- Stage:Seed, Series B
- Geography: United States, Denmark, Switzerland
Investor stats
- Total investments: 4
- Round size: Seed $5M–$5.7M; Series B $30M–$193M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Jabbr — Jabbr allows to capture boxing matches with a virtual video production.Its goal is to make video production and advanced performance analytics in combat sports available to anyone with a smartphone.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- KoBold Metals — Finding the materials of the future with AI and HI
Zürcher Kantonalbankand
Show more...Investment focus
- Industry: Medical Device, Energy, Leasing
- Stage:Seed, Series A, Series B
- Geography: Switzerland
Investor stats
- Total investments: 6
- Round size: Seed $1.2M–$4.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aspivix — ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
- Positrigo — NeuroLF is an ultra-compact brain Positron Emission Tomography system. Our technology makes functional imaging accessible for people worldwide.
- Spacewise — Find out how to optimize revenue & occupancy, and attract exciting new tenants.
For the last 10+ years, I've had the rare fortune of working with world-class entrepreneurs - as a venture or angel investor, startup team member or growth advisor - in the US and in India. Experience: US VC - Investor @ NEA India VC - Principal & Founding Member @ Lightbox (ex. Kleiner Perkins India and Sherpalo) Startup ops in the US- VP, Bus Dev and early employee @ EverFi (one of the largest edtech networks globally) Startup ops in India - Key leadership responsibilities related to 4 Lightbox companiesCurrently, I am especially spending a large portion of my time on blockchain startups and cryptocurrencies. INVESTING: Lots of learnings from working on early to growth stage investments. US: Millennial Media (IPO, acq. by AOL), OPOWER (IPO, acq. by Oracle), Gilt Groupe (acq. by Saks / Hudson Bay), ChannelAdvisor (IPO), AddThis (acq. by Oracle), EverFi, Suniva, Videology, Credibase, new crypto and blockchain projects India: Droom, Melorra, Paymate, Zoomin, Stalkbuylove, Fynd, The Better India, Mech MochaSTARTUP OPERATIONS: Hands-on experience in both hyper-growth and turnaround situations. Wore a few hats as an early employee and head of BD at EverFi (one of the largest edtech networks globally having served 16MM students and raised $250MM), led strategic finance projects for NEA companies Suniva and AddThis, and interned at InMobi. Owned or helped solve problems across strategy, M&A, senior hiring, int'l expansion and fundraising while working closely with management at Droom, Melorra, Paymate and Zoomin
Show more...Investment focus
- Industry: Financial Services, Software, Information Technology
- Stage:Pre-Seed, Seed, Grant
- Geography: India, United States, Germany
Investor stats
- Total investments: 46
- Round size: Seed $572k–$11M; Pre-Seed $165k–$2M
- Lead/follow: 72% lead, 28% follow
Portfolio highlights
- Klub — India's leading Revenue Based Financing platform with a vision to revolutionize growth capital. Join the Klub for fast, fair & flexible funding.
- StayQrious — StayQrious is an ed-tech startup that focuses on skilling students in computer applications such as coding through online group classes. The company also focuses on collaboration, critical thinking, and creativity through these virtual classrooms.
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Edward Ludwig has been a Member of the Board of Directors of Boston Scientific since March 2014. Edward is the former Chairman of the Board of Directors of Becton, Dickinson and Company (“BDX”), a global medical technology company, having served in that position from February 2002 through June 2012. Edward also served as BDX’s ChiefExecutive Officer from January 2000 to September 2011 and as its President from May 1999 to December 2008. Edward joined BDX as a Senior Financial Analyst in 1979. Prior to joining BDX, Edward served as a Senior Auditor with Coopers and Lybrand (now PricewaterhouseCoopers) where he earned his CPA and as a financial and strategic analyst at Kidde, Inc. Edward serves as Lead Director on Aetna Inc.’s Board of Directors and chairs its Finance Committee and is a Member of the Board of Directors of Xylem, Inc. Edward serves as the Non-Executive Chairman of POCARED, a privately held firm in Israel. Edward is also a Member of the Board of The Center for Higher Ambition Leadership, which is dedicated to studying, documenting and advancing the principals of Higher Ambition Leadership that drive the most successful enterprises in terms of longer term shared value creation. Edward served as a Member of the Board of Trustees of the College of the Holy Cross (2005-2013), and the Columbia Business School Board of Overseers (2010-2015). Edward also served as a Member of the Board of Trustees of the Hackensack University Medical Center Network Board of Trustees. Edward received a B.A. degree in Economics and Accounting from The College of the Holy Cross and a MBA degree from Columbia University.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Series A, Corporate Round
- Geography: Switzerland, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIOM —
- LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
- Velano Vascular — Establishing a new standard of care for inpatient blood draws by improving the experience and reducing pain, risks and inefficiencies of existing practices.
Dr. Ronjon Nag is CEO/Co-Founder of Cellmania & R42 Group, a leading wireless applications company. Dr. Nag, is an acknowledged authority in the mobile industry, having been featured on the cover of Fortune and involved in the development of, and holding patents in, wireless applications, user interfaces and new m-commerce distributionmethods of mobile applications and devices. Previously a Vice President and General Manager at Motorola responsible for smart mobile technologies developed in the Lexicus Division and Motorola Human Interface Laboratories worldwide, hundreds of millions of Motorola devices have shipped with technology developed under his leadership - voice recognition, handwriting recognition and predictive text key systems. Previously Dr. Nag was CEO/founder of Lexicus, a pioneer of speech and handwriting recognition technology, acquired by Motorola in 1993. Dr. Nag holds a Ph.D. from Cambridge University (speech recognition research), was a Harkness Fellow at Stanford University (neural network research), has an MBA from MIT, and a 1st class Honours degree of Birmingham University, UK (electrical engineering).
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Pre-Seed, Series B
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 14
- Round size: Seed $1.2M–$13M; Pre-Seed $472k–$2M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Introhive — Introhive is a Relationship Intelligence platform that helps firms overcome data silos and unlock actionable relationship insights that drive collaboration and growth.
- Civil Maps — The Civil Maps sensor-agnostic platform enables high-accuracy, low-cost 3D HD mapping and localization at scale. Auto OEMs, mapping companies, and mobility providers use our technology to advance their autonomous driving initiatives by integrating our localization technology with their decision-making stack and sensor configurations of choice.Civil Maps enables vehicles to develop and leverage their own “mental model” of the world; they can can create, utilize, and create maps with the industry’s most cost-effective, scalable, and robust methods available today. Civil Maps’ proprietary Fingerprint Basemap Technology is at the core of our offerings in sensor fusion, 3D mapping, centimeter-accurate localization at scale. While empowering vehicles with full environmental awareness and enhanced safety, Civil Maps is able to dramatically reduce the cost, compute, and energy requirements involved in continental-scale deployment of delivery bots and autonomous vehicles.
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
Katelyn Donnelly is the General Partner at Avalanche VC. She attended Duke University.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Education
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Germany
Investor stats
- Total investments: 12
- Round size: Seed $1.1M–$13M; Pre-Seed $600k–$1.4M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Bluesky — Bluesky is a new social media platform.
- Molecule — Molecule is a collaborative platform, where stakeholders in drug development work together to accelerate the process of bringing novel therapeutics to patients. We connect leading researchers to investment opportunities by turning intellectual property and its development into a liquid and easily investable asset.
- Civic Marketplace — Civic Marketplace is a platform that simplifies purchasing decisions, helps agencies make efficient, informed choices, and boosts local economic growth by providing access and opportunities to historically underutilized businesses.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investment focus
- Industry: Artificial Intelligence, B2B, CRM
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland, United States
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Veezoo — Veezoo empowers individuals to find actionable insights from data by literally just asking questions in plain English!
- Ridge AI — Ridge AI makes it fast and easy for SaaS companies to prove value inside their product.
- Golden Analytics — Golden is an AI-native BI platform that makes data easy, powerful & beautiful.
Christopher Gibson is based out of Salt Lake City, Utah, and is the Interim Executive Advisor, Co-Founder and Chairman of the Board of Directors of Recursion Pharmaceuticals. Christopher previously worked at Cure Hereditary Hemorrhagic Telangiectasia as a Member of the Board of Directors. Christopher Gibson attended the University of Utah.Christopher Gibson has been awarded the 2013 TEDMED Front Line Scholar.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 25
- Round size: Seed $5.4M–$14M; Series A $12M–$55M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zanskar — Zanskar Geothermal & Minerals uses custom AI tools and geoscience models to analyze vast amounts of data and pinpoint untapped geothermal hotspots.
- Play Health — Delivering data & AI-driven (peri)menopause care software to improve outcomes today, developing precision medicine infrastructure for tomorrow.
- Dunia Innovation — Catalysing the energy transition.
Marc Maurer is based out of Zürich, Zurich and is the Board member of Liom. Marc previously worked at On as a Co-CEO. Marc Maurer attended the Zurich University of Applied Sciences/ZHAW.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A
- Geography: Switzerland
Investor stats
- Total investments: 2
- Round size: Series A $16M–$18M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- LIOM — Pioneering in non-invasive glucose monitoring technology, seamlessly integrated with health metrics for a revolutionary wearable experience.
- Cerrion — Cerrion is a visual AI that helps production teams react faster to process deviations, automate root cause analysis, and implement targeted improvement actions. They believe that process transparency enabled by AI and computer vision is key to achieving more autonomy and sustainability in manufacturing. Their software is built and designed withproduction teams from all over the world in the loop.
Thomas Glocer is based out of New York, New York, and is the Co-Founder and Vice Chairman of the Board at BlueVoyant. Thomas previously worked at Thomson Reuters as a CEO. Thomas Glocer attended Yale Law School.
Show more...Investment focus
- Industry: Software, FinTech, Analytics
- Stage:Seed, Series A, Series C
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 54
- Round size: Seed $1M–$7.7M; Series A $5M–$24M; Series C $13M–$27M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Superlegal — Superlegal is an AI Law Firm for Builders. Get your contracts reviewed and redlined by AI and commercial attorneys. Contract Review - Built Like Software, Practiced Like Law.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.
Lukas Speiser is the founder and CEO of Amorana.ch
Show more...Investment focus
- Industry: Health Care, SaaS, Retail
- Stage:Seed, Pre-Seed
- Geography: Switzerland, Germany
Investor stats
- Total investments: 8
- Round size: Seed $161k–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Dunatura — Dunatura engages in the manufacture and supply of vitamins and micronutrients.
- Cleveron — Cleveron is an innovative Swiss start up company that has developed an intelligent system for radiator heating systems. With Cleveron, the room temperature in each individual room of a building can be individually and optimally controlled. This can save costs and energy. Simple Home's technology makes an active contribution to reducing CO 2emissions.They have the vision to make part of the big, public buildings in Switzerland and Europe, such as school buildings and administrative buildings, more environmentally friendly. To make this happen, they want to convince cities and communities to convert their buildings to Cleveron technology as quickly as possible. Because with the conversion they are now making a concrete contribution to the rescue of the climate.
- NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Tobias Reichmuth - Founding Partner at Maximon - The Longevity Company Builder @ Maximon
Show more...Investment focus
- Industry: E-Commerce, Travel, Internet
- Stage:Seed, Angel, Pre-Seed
- Geography: Switzerland
Investor stats
- Total investments: 8
- Round size: Seed $327k–$2.6M; Angel $138k–$1.7M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Firstcar — Firstcar provides car driving learning assistant services. They offer services that include hand-picked driving schools, student cars with double pedals for rent before and for the driving test, entry-level vehicles that are inexpensive to buy and maintain, support and advice on vehicle purchase, and selected insurances with special rates.
- MyFeld.ch — MyFeld.ch is the holder of a fresh farm food platform that aims to create a digital link between consumers and our local agriculture. The company's platform provides products directly from the farm, allowing people to improve their comprehension of seasonality and regionality while also raising awareness of the sustainable use of food byallowing them to purchase fresh produce from the farm.
- Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
Thomas Zehnder - Partner @ BlueOcean Ventures
Show more...Investment focus
- Industry: Health Care, Life Science, Biotechnology
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Testmate Health — 2 in 1 urine test with immediate results for Chlamydia trachomatis and Neisseria gonorrhoeae. Results within minutes & 100% anonymous.
Arda Kara
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Series A, Seed, Series B
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 9
- Round size: Series A $26M–$38M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Human API — Health data platform that connects to all data sources, enabling companies to build new technologies & deliver better experiences to customers.
- Levels — Improve metabolic health with CGM, comprehensive labs, and a personalized plan.
- Blackrock Neurotech — Blackrock Neurotech innovative brain technologies provide new hope for people with paralysis & other neurological disorders.
Miklos Stanek joined BackBone Ventures as Founding Partner & Chairman.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed, Series A
- Geography: Switzerland
Investor stats
- Total investments: 6
- Round size: Series A $5.8M–$7.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Neon — With neon, you can pay, save and manage your money. Digitally, securely and with no hidden fees. Open your account online in less than 10 minutes!
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Healthcare has been my passion throughout most of my professional life – in international corporate environments and as entrepreneur and Business Angel. I co-founded medneo (https://www.medneo.com/) (Radiology as a Service) and OpenRad (https://www.openrad.com/) (IT rails for diagnostic imaging) and helped to buildit from zero to 550+ people – what a journey. I recently transitioned from Group CEO to the supervisory board. With medneo (https://www.medneo.com/) we are improving access to high-end diagnostic imaging (e.g. MRI, CT, etc.) for patients with a new pan-European operating model for medical service providers: Radiology as a Service. And with OpenRad (https://www.openrad.com/) we bring workflow IT to 3rd party diagnostic centers beyond medneo. I have developed the organization for CEOs to manage the brands independently and I support them actively as board director. Together with my two co-founders André Glardon (https://www.linkedin.com/in/andreglardon/) and Matthias Issing (https://www.linkedin.com/in/matthias-issing/) we – 3minds (https://www.linkedin.com/company/3minds-projects/) – are supporting outstanding impact entrepreneurs on their journey to improve our lives - as angels, mentors and in board functions. We engage directly and via amazing networks like Better Ventures (https://www.betterventures.io/) and Springboard Health (https://www.springboardangels.com/). I'm a grateful member of the Entrepreneurs' Organization (https://eonetwork.org) - the meaningful connections with diverse and inspiring people helped me to grow as a person. Also, I'm a board member of EO's Berlin Chapter (https://www.eoberlin.com/). Berlin (https://goo.gl/maps/6zP6kaWtrY7VQhvu6) based. Originally from the south of Germany (Pforzheim), had the opportunity to live and work abroad (e.g. USA, UK, China). I like endurance sports, especially long-distance running (Marathon+) and cycling. I'm happy to contribute and connect (https://about.me/nicolas.weber) - feel free to reach out! https://www.linkedin.com/in/nicolasweber/
Show more...Investment focus
- Industry: Genetics, Oncology, Health Care
- Stage:Seed, Pre-Seed
- Geography: Switzerland, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sanome — Sanome are combining different types of biomarkers to develop engaging, useful and accurate diagnostic products (IVDs) that enable early detection and prevention of disease. The IVD innovation engine, will ultimately enable new approaches for healthcare delivery, providing access to novel at-home testing paradigms for all people.
- Qnomx — Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Alexsis is the Founder and Managing Partner of Merian Ventures, an early-stage venture firm focused on investing in women founded, co-founded and majority-owned companies in the US and UK. Alexsis has extensive investment, venture and operations experience based on businesses she has founded or funded. As managing partner of Merian Ventures since2015, Alexsis serves as a Board Member and Advisor to Merian Venture portfolio companies Provenance, Pivigo, Populus, Honeycomb, ImpactVision, CareerLark, Cirrus Identity and Compaas, among others. Merian Ventures was named after Maria Sibylla Merian, a botanist, entrepreneur and intrepid traveler born in 1647. In addition to Merian Ventures, Alexsis is a US-UK Fulbright Commissioner; Board member of the Oxford Internet Institute; Board member of The Oxford Foundry; Founder and funder of the WEInnovate STEM accelerator for Women at Imperial College, London; and Board Member and Advisor to companies she's funded. Alexsis is also Chairman and Founder of The Althea Foundation, established in 2003 as a family office. Today, The Althea Foundation is a California nonprofit public benefit corporation and it is recognized by the Internal Revenue Service as a public charity described in Internal Revenue Code Sections 501(c)(3) and 509(a)(1).
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 8
- Round size: Seed $250k–$2.9M; Series A $2.1M–$24M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Aiden — Reduce risk, enhance compliance, and simplify IT with modern, intelligent software packaging and deployment using Artificial Intelligence.
- Compaas — Compaas: The Compensation Platform | Total Visibility. Zero Spreadsheets. Painless raise cycles, compensation metrics, people analytics, rewards letters
- Provenance — Provenance is a software solution for sustainability communications and supply chain transparency.
Tej Tadi is an Electronics Engineer and has pursued an advanced master in Virtual Reality & Computer Graphics at The Swiss Federal Institute of Technology (EPFL), Switzerland. During his PhD (EPFL), he set up an immersive virtual reality system in combination with state-of-the-art brain imaging technologies enabling trans-disciplinary work incognitive psychology, neuroimaging, and virtual reality. His research has led to important and highly visible scientific publications (Science) and awards (Pfizer Award for Neuroscience in 2009). Through his research, he has built a strong multi-disciplinary base spanning computer science, systems biology, neuroimaging, and computational and cognitive neuroscience. He founded MindMaze in 2011 to design and develop novel applications in Neuro-Rehabilitation, Game training & Interfaces. The technology platform from MindMaze will help in the neurology, psychiatry and sports rehabilitation.
Show more...Investment focus
- Industry: Robotics, Neuroscience
- Stage:Seed
- Geography: Switzerland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Metaphysiks — Metaphysiks is a groundbreaking immersive technology company combining world leading neuroscience and robotics to create multisensory experiences.
As an early pioneer in long DNA synthesis, Emily is poised to accelerate the biofactory market. She and co-founder Bill Peck share the world record for synthesizing the longest, highest quality oligo library. Emily architected the successful SureSelect product line which lowered the cost of sequencing and elucidated dozens of mendelian diseases,and she developed Agilent’s Oligo Library Synthesis technology. Emily has co-authored over 34 peer-reviewed papers—many on synthetic DNA—and has extensive marketing, management, and business development experience. Prior to Twist Bioscience, Emily was Director of Applications and Chemistry R&D—Genomics at Agilent Technologies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Product Research
- Stage:Seed
- Geography: United States, Switzerland
Investor stats
- Total investments: 3
- Round size: Seed $1.5M–$5.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biostate AI — Biostate AI develops generative AI that benefit all human health.
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Kiwi Biosciences — Kiwi biosciences is a biotech company that develops enzymes to make food for patients who suffer from Irritable Bowel Syndrome (IBS). The company was founded in 2020 and is based in Somerville, Massachusetts, United States.
Philip Wels is an individual investor.
Show more...Investment focus
- Industry: Information Technology, Sports, Software
- Stage:Pre-Seed, Seed
- Geography: Switzerland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Riverkin — Riverkin builds rugged, low-cost water sensor systems for rivers that measure turbidity and temperature in real time. Our platform turns field data into clear insights and decision making tools.
- BreezeLabs — Most runners track their performance.
- MindMetrix — MindMetrix is a startup project team of ETH Zurich which envisions products that quantify the performance of your mind and mental wellbeing.
Feike has been the CEO and Chairman of the Managing Board of Directors of Royal DSM N.V. (a global Life Sciences and Materials Sciences company) since May 2007. In 1995, Feike became director of Gist-Brocades Food Specialties Division and joined Gist-Brocade’s executive committee. Following the acquisition by Royal DSM N.V. in 1998, he became adirector of the business group DSM Food Specialties. In 2000 he joined Royal DSM’s managing board of directors, becoming Chairman and CEO in May 2007.He is currently a member of the supervisory board of De Nederlandsche Bank (DNB, the Dutch Central Bank), and a board member of CEFIC (European Chemical Industry Council) and member of the Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).His previous roles have included member of the Supervisory Board of DSM Netherlands, the Utrecht University, the Dutch Genomics Initiative (NGI) and the Anthonie van Leeuwenhoek Hospital/Netherlands Cancer Institute (NKI/AVL), chairman of Chemical Governors and a Global Agenda Council of the World Economic Forum, Dutch Food Chain Sustainability Foundation (DUVO) and of EuropaBio (European Biotech Association), a member of the Dutch Innovation Platform 2.0, board member of BIO (US Biotechnology Association), the Swiss Society of Chemical Industries (SCGI) and the Dutch Nutrition/Food Top-Institute (WCFS) and a member of the advisory board of ECP-EPN (e-commerce) and the Rotterdam Business School of the Erasmus University.
Show more...Investment focus
- Industry: Biotechnology, Bioinformatics, Pharmaceutical
- Stage:Seed, Series B
- Geography: Switzerland, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cradle — Using robust prediction algorithms and AI design recommendations, Cradle assists biologists in rapidly designing better proteins. Cradle gives you complete ownership of the intellectual property while maintaining the privacy and security of your sequences and data.
- Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.
Biotech Angel investor funding in Switzerland at a glance
Stats across 42 deals from 75 investors.
Access all 75 angel investors in Switzerland Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in Switzerland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 75 angel investors investing in Switzerland Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!